Gyre Therapeutics, Inc. GYRE Current ratio

Current ratio at other companies

Eli LillyLLY

1.4×+0.1×

Madrigal Pharmaceuticals, Inc.MDGL

3.2×-1.9×

Viking TherapeuticsVKTX

5.7×-38.5×

Theravance BiopharmaTBPH

13.5×+6.8×

Rigel PharmaceuticalsRIGL

2.6×+0.4×

Zevra Therapeutics, Inc.ZVRA

5.2×-2.7×

FAQ

What is Gyre Therapeutics, Inc.'s current ratio?

Gyre Therapeutics, Inc. (GYRE) reported current ratio of 4.3× in Q2 2026.

How has Gyre Therapeutics, Inc.'s current ratio changed year-over-year?

Gyre Therapeutics, Inc.'s current ratio decreased by 21.1% year-over-year, from 5.4× to 4.3×.

What is the long-term trend for Gyre Therapeutics, Inc.'s current ratio?

Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s current ratio has grown at a 4.5% compound annual growth rate (CAGR), from 5× to 6.3×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.